First Three Children to Commence Treatment With Ryoncil^®

Mesoblast announced that it has entered into the Medicaid National Drug Rebate Agreement with the US Centers for Medicare & Medicaid Services, Department of Health and Human Services, for Ryoncil®, the first MSC therapy approved by the US FDA for any indication.